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Abstract 
The pharmaceutical industry is in the midst of a fundamental transformation. Institutional 
regulations that have been in place for decades are being removed and competitive 
pressures force pharmaceutical companies to adopt customer-oriented strategies. 
Information technology which has traditionally been applied to many processes in this 
industry is an important enabler for the interaction with key customer segments such as 
physicians and patients. However, developing and transforming customer relationships is 
merely a technological undertaking. Changes are required regarding strategy, processes 
as well as the systems architecture. To develop an integrated customer relationship 
management strategy this research draws on elements from established business 
redesign. The emphasis is on portals that bundle services for the patient’s and 
physician’s customer processes. This architecture framework has been elaborated in 
cooperation with nine companies and applied at a major pharmaceutical company. 
1. Introduction 
1.1 Information Technology in the Pharma Industry 
The pharma(ceutical) industry is currently undergoing a period of fundamental change. 
Structural changes, such as the direct sale of prescription drugs, increasingly well-
informed patients, the growing number of cost reductions of governments and health 
insurance providers as well as new Internet-based initiatives have significant impact on a 
pharma company’s relationships with its customers. In this competitive market 
environment developing and selling high volume products (‘blockbusters’) to physicians, 
hospitals, and wholesalers is simply no longer sufficient. Like in other industries 
increasing customer retention by expanding and personalizing the services offered to 
customers becomes a strategic imperative. Compared to the banking or high tech sector, 
pharma companies still have a strong focus on their products and are only at the 
beginning of systematically managing relationships to customers [35]. Kalustian et al. 
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[18, 64] observed that customer relationship management (CRM) “has become a pharma 
buzzword, but few companies actually practice it.” Among the goals of CRM are to 
enhance the intensity of interaction with customers across one or more touch points and 
to establish a uniform view on customer data [14, 81], [16, 31]. This helps to address 
attractive customers, to decrease the cost of serving customers, and to increase customer 
retention by providing tailored offerings to existing and new customers [33, 102].  
Although pharma companies are not at the forefront of adopting CRM systems, 
information technology (IT) the industry has pioneered many customer oriented 
applications of IT in the past. First, interorganizational information systems (IOS) 
improved the relationships to professional customers and well known examples for the 
strategic use of IT such as the ordering systems from Baxter (formerly American Hospital 
Supply) and McKesson originate from this industry [20, 209]. Secondly, hospitals are 
operating internal systems to improve the healthcare process, e.g. administrative systems, 
telemedicine, patient records [32]. Devaraj/Kohli report that IT-enabled business process 
redesign initiatives from hospitals had a positive impact on the satisfaction of their 
patients [11, 62]. Thirdly, the advent of the Internet more brought more circulation of 
product and disease information to customers, the support of campaigns and clinical 
trials, and the possibility of providing more value added to customers [22, 102]. The 
buzzwords e-health and e-healthcare refer to the application of Internet technology to 
pharma processes [9, 207] and the entire online drug industry is expected to grow 
significantly in the long-term last but not least due to the IT-affinity and the increasing 
role of healthcare to the ‘baby boomers’ [37, 445].  
1.2 Goal of Paper and Research Methodology 
The IT-driven transformation in the pharma industry creates strategic opportunities and 
competitive pressures at the same time. On the one hand, existing and new players are 
developing websites and portals for customer interaction as well as for enhanced quality 
of care [19]. On the other hand, the Internet creates opportunities for pharma companies 
to improve the depth and/or breadth of interaction with existing and new customer 
segments. Both effects emphasize Porter’s view that Internet technologies are 
complementary to existing interaction channels (e.g. sales force, call centers) and need to 
leverage a company’s existing competencies [31]. Therefore, pharma companies are 
forced to assess their existing strategies and to (re)position themselves. It is the goal of 
this paper to present a framework for understanding the changes and for developing 
solutions for electronic customer interaction for a pharma company.  
CRM systems from Siebel, SAP and others are key enablers for CRM strategies as they 
provide a consistent and consolidated customer database, electronic support for customer 
interactions, and sophisticated analytical tools. However, CRM projects are merely 
technological. Studies show that the organization around the customer, the prototyping of 
new (electronic) processes, and cultural factors determine CRM adoption [39, 205], [42, 
18]. Business process redesign (BPR) methodologies such as business engineering 
recognize the process as the link between strategy and systems development [28, 20]. 
However, these BPR methods have mainly been applied to processes within organizations 
and are not focused on shaping customer-oriented solutions.  
In cooperation with nine international companies an architecture framework has been 
developed between 2000 and 2002 for customer and supplier interaction. Based on 
individual research projects with each company, the research team drafted an architecture 
which was subsequently refined in several workshops with representatives of the partner 
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companies.1 In applying the architecture at Pharma Corp, one of the largest pharma 
companies worldwide, this research follows the tradition of action research where the 
researcher is directly involved in the project work [38, 20].  
2. Transformation of Downstream Processes  
2.1 Challenges for Pharmaceutical Companies 
Currently, a variety of changes is taking place which influence a pharma company’s 
downstream (or customer facing) relationships. Innovations in R&D and CRM are seen as 
the main areas of action for pharma companies [8]. While the former are an established 
research topic addressing product innovation, the latter is a young field in the pharma 
industry. Considering that over 110 million people are estimated to look for health-related 
online information each month in the US alone, the Internet has significant potential [44]. 
Among the major challenges for CRM are: 
• Demanding healthcare customers. More competition increases the negotiation 
power of patients who demand more value at lower prices and more freedom of 
choice regarding healthcare providers [43, 9]. More active and informed patients 
increasingly influence the choice of drugs and reduce the physician’s role as 
decision-maker. Pharma companies need to include the specific requirements of 
both patients and physicians in their strategies.  
• Restricted access to physicians. The number of visits of the pharma sales reps to 
present products (‘detailing’) is set to decrease due to regulation in various 
European countries and the doctors’ falling acceptance. At the same time, the 
number of sales reps in the 40 largest pharma companies has doubled while 
prescriptions have only grown by 15% [3, 256]. Pharma companies not only need 
more efficiency in their sales force, but also must exploit new interaction 
channels with this key customer segment. 
• Increasing cost pressure. To contain health costs, governments are exerting 
increasing pressure on the prices of pharma companies. At the same time, parallel 
imports from low-cost countries and the growing competition from generic drug 
manufacturers are eroding margins. Many pharmaceutical companies have 
therefore decided to optimize their sales strategies by introducing key account 
management structures [30]. 
• Declining regulation. Council Directive 92/28/EEC of March 31, 1992, for 
example, prohibits the advertising of medical products for human use among end 
users in the European Union. The US removed these restrictions in 1997 and 
similar developments are now expected for Europe [5, 62]. Pharma companies 
need to include direct sales and marketing in their strategies since online 
pharmacies, procurement platforms or health portals may intermediate the 
pharma company’s customer access [24].  
                                                     
1 For more information on this multilateral research design see [1, 11]. 
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2.2 Potentials of CRM 
Xu et al. define CRM as an “all-embracing approach, which seamlessly integrates sales, 
customer service, marketing, field support, and other functions that touch customers” [41, 
442]. By systematically collecting and analyzing information on customer contacts CRM 
aims to maximize the lifetime customer value [40, 94]. In the pharma industry multi-
channel CRM approaches are suggested which integrate traditional sales force and 
Internet-based channels (eCRM) [15]. These will lead to improvements in three areas: 
• Market or customer segmentation is the basis for differentiated customer service 
[25, 378] and recognizes that neither patients nor physicians are homogeneous in 
their requirements. For example, opinion leaders can be segmented in four 
different physician types [21, 165] and patients depending on their disease. 
Patients with chronical diseases are long-term patients who invest time in 
understanding their disease as well as possible medication alternatives. Patients 
with acute diseases are often only interested in standard information on 
combating symptoms to overcome their disease. CRM should also aim at 
expanding the needs of this segment, e.g. from short-term illness to long-term 
wellness [10, 8]. 
• Based on a fine-grained segmentation pharma companies are able to offer value 
added services that go beyond the selling of drugs and ‘blockbusters’2. These 
services support the specific customer segments in all stages of their life cycle. 
For example, chronical bronchitis patients could be provided in-depth 
information on cortisone and antibiotics as well as various drugs which are 
necessary during the course of their illness. Patients with acute diseases could be 
offered standard drug information to combat high temperatures, chest pains or 
coughing and general prevention advice. 
• Cross-/Up-selling are one outcome of integrated customer knowledge across a 
pharma company’s divisions, such as diagnostics and pharmaceuticals. For 
example, a physician who works with diabetes patients and uses a pharma 
company’s equipment for blood analysis can also be offered drugs for preventing 
weight problems (cross-selling). The same applies within individual product lines 
to support sales of a higher-grade product (up-selling). 
2.3 Limitations of Traditional Sales and Marketing 
The present sales organization in many pharma companies is oriented towards three 
customer segments: (1) physicians (2) hospitals, wholesalers and pharmacies, and (3) end 
customers, i.e. patients [22, 101]. While computer manufacturers such as Dell deal with 
the end customer direct, a pharma company’s main customers are physicians, pharmacies, 
hospitals, and patients. For interaction with these customer groups, pharma companies 
use different systems today:  
• Systems for Territory Management (TMS) or Sales Force Automation (SFA) 
have been in operation for some time and support the sales force in visiting 
physicians on a regular basis. A study conducted in Austria shows that good sales 
reps still determine customer satisfaction and lead to indirect economic success 
[34, 964]. 
                                                     
2 Products with annual revenues of USD 500 million or more [10]. 
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• KAM is an enhanced form of TMS, where dedicated key account managers look 
after major customers such as hospitals, wholesalers, hospital buying syndicates 
and other decision-makers.  
• Call centers and portal applications are emerging in certain countries for 
physicians as well as for patients. Examples are portals for specific diseases (e.g. 
oncology) or products (e.g. Aspirin). Patients are currently not addressed due to 
regulation and complex relationships between end customers and the pharma 
companies in Europe.  
 
Figure 1 shows the evolution of these systems at Pharma Corp. Customer information is 
neither systematically gathered and communicated between the local marketing divisions, 
nor are interactions with customers on portals or call centers coordinated with the existing 
KAM or TMS. This impedes to identify customer segments (e.g. chronically ill patients), 
to develop the required additional services, and to use the potentials of up-/cross-selling. 


















































Figure 1: Customer Segments and Channels in the Pharmaceutical Industry 
3. Development of a Customer-oriented Architecture 
Architecture is an instrument for the systematic development of solutions in many areas 
such as civil and systems engineering. In the latter it describes the integration of different 
components to deliver one or more (technological) capabilities [36]. Although various e-
business architecture frameworks have emerged (e.g. [12]) these are mainly technology-
driven. In the following a top-down approach is described that encompasses three levels: 
a business architecture which provides the frame for understanding the transformation of 
the sales channels within the industry, a process architecture which develops the main 
design elements for shaping customer-oriented services, and a systems architecture which 
structures the supporting applications.  
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3.1 Strategy: Business Architecture 
3.1.1 Analysis of Downstream Actors and Relationships 
On a strategic level customer orientation requires a sound understanding of the 
downstream business network which depicts all actors involved [33, 102]. Figure 2 
shows the existing business architecture with Pharma Corp’s marketing, sales and service 
departments as well as the customer segments along the various interaction channels 
(business-to-business, business-to-doctor, business-to-consumer, and business-to-
government).3 This structure represents the European market since the greatest changes 
were expected here.  
• Physicians are the most important customers for pharma companies as they 
possess the authority and the know-how to decide on the prescribed products.4 
Nearly all academic physicians and a growing number of community physicians 
are regularly using the Internet [27, xii]. Pharma companies strive to reduce the 
current cost of EUR 1,000 per visit and to increase the length of each visit which 
today takes only approx. nine minutes [17].  
• Although physicians make the product decision, patients are the final buyers of 
pharma products [16, 32]. They are more likely to prepare themselves for 
discussions with their doctors and have independently decided on their preferred 
drug [23, 494]. Pharma companies aim at providing information which may 
influence the choice of drugs.  
• Hospitals are high-volume customers for medicines. For example, the hospitals in 
Switzerland purchased 20.7% of prescription medicines in 2000 [6]. Although 
product decisions are still influenced by physicians, hospitals increasingly 
employ professional procurement staff that exerts competitive pressures on 
pharma companies.  
• Wholesalers are not regarded as customers but rather as a distribution channel. In 
Switzerland the three largest wholesalers (Galenica, Amedis and Voigt ) together 
command a 90% share of the market, while in most of Southern Europe the 
market is still less concentrated. Consolidation is expected to increase, for 
example, the three largest wholesalers already operate throughout Europe and 
aim at downstream integration of pharmacies and hospitals. 
• Pharmacies sell drugs to patients on a prescription basis. In 2001 pharmacies sold 
55.6% of all prescription drugs in Switzerland [6]. Pharmacies buy their drugs 
from wholesalers and do not source direct from pharma companies. 
• Patient groups are interest groups who offer information and support regarding 
specific illnesses. They influence politics and the pharma industry [7]. An interest 
group, for example, was effective in securing approval of Herceptin (a drug used 
against breast cancer) by promoting the drug to gain faster approval from the 
food and drug administration (FDA) [2, 7]. Pharma companies aim at addressing 
these patient groups with suitable services and information at the right moment in 
time.  
 
                                                     
3 Since the business-to-government area does not have a direct impact on sales activities it is not analyzed here. 
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Figure 2: Traditional Business Architecture in the Pharma Industry 
3.1.2 Transformation of Business Architecture 
The Internet has spurred a variety of websites, portals and marketplaces which various 
players in the downstream pharma network have used. Portals are websites that 
personalize and integrate information on products and services from different vendors and 
applications. While portals bundle information to provide a maximum coverage of 
customer processes, marketplaces provide a transaction infrastructure among competing 
suppliers using market mechanisms (e.g. auctions). Pharma companies have established 
solutions to five customer segments (see 1 in Figure 3): 
• Patients receive information and services concerning diseases or therapies. 
Among the examples are lillydirect.com for oncologists by Eli Lilly, 
raacademy.com for patients with rheumatoid arthritis or ibreathe.com for asthma 
patients by GlaxoSmithKline (see also [22, 102]). 
• Hospitals are offered catalogs for electronic procurement with multiple pharma 
companies. To prevent hospitals from using order entry systems from various 
pharma companies in parallel, marketplaces such as GHX have been established 
in cooperation with competitors.5 
• Physicians obtain information on drugs, treatments, current research as well as 
support in their operational processes and in training. Several companies have 
started online and interactive product presentations to supplement or substitute 
physical sales rep visits (‘eDetailing’) [3, 256], e.g. MyDoc Online from Aventis. 
• Pharmacies and wholesalers receive only little information from pharma 
companies. The former are traditionally the wholesaler’s customers and the latter 
have their own ordering systems in place. 
 
Wholesaler portals (see area 2 in Figure 3) support electronic ordering and the purchase 
of drugs between multiple pharma companies and pharmacies. Often they build upon a 
wholesaler’s established electronic ordering system. 
                                                     
5 Founders of GHX are Johnson & Johnson, GE Medical Systems, Baxter, Abbott Laboratories, and Medtronic. 
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Pharmacy portals emerged in two directions (see 3 in Figure 3). First, pharmacies 
establish websites that include electronic chats with the pharmacist or ordering services 
which enable patients to enter the required drug, fax the prescription and collect the 
product in the physical store. Second, virtual pharmacies in the US and the UK offer 
electronic catalogs, order entry and prescription handling. Among the remaining 
examples are drugstore.com or cvs.com.6  
Among the hospitals the medical schools are offering a wealth of medical information on 
their websites. An analysis of the top fifty-one medical schools in the US showed that 
especially the higher ranked schools had broad and deep information on diseases and 
therapies etc. [44]. 
New information providers (see 4 in Figure 3) include telemedical services for 
exchanging multimedia data (e.g. reports, x-rays, insurance number, etc.) between 
physicians and patients [26]. Other portals provide in-depth knowledge on drugs and 
healthcare (e.g. drkoop.com, webmd.com) or offer e-detailing services (e.g. 
iPhysicianNet). To ensure the quality of medical information the Health on the Net 





































Figure 3: Future Business Architecture in the Pharma Industry 
 
When Pharma Corp evaluated the changes in their business architecture in 2001 they 
decided to provide state-of-the-art regarding their websites (e.g. uniform layout 
worldwide, consistent product information), to maintain parity in the area of online 
pharmacies and downstream marketplaces (i.e. act upon strategic necessity), and to 
develop competitive advantages by establishing portals for specific customer segments. In 
a number of workshops with Pharma Corp’s country organizations, the existing and 
expected importance of the customer segments was evaluated. As Figure 4 suggests, 
patients and wholesalers should receive more attention in the future. However, physicians 
still remain the most important segment for pharma companies. 
                                                     
6 For an overview on existing verified internet pharmacy practice sites (VIPPS) in the US see the National Association of 
Boards of Pharmacy (http://www.nabp.net/vipps/consumer/listall.asp). 
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Figure 4: Importance of Customer segments at Pharma Corp 
3.2 Process Architecture 
3.2.1 Customer Processes Analysis 
On the process level Pharma Corp analyzed each customer segment to identify required 
and valued services to be included in a portal. The customer process encompasses all 
tasks which customers go through in order to satisfy their needs [29, 48]. Internal 
workshops and customer surveys in six European countries with an average of ten sales 
and marketing representatives were conducted. Three hospitals, two buying syndicates 
and two wholesalers took part in the external survey. From this analysis the customer 
processes as well as possible portal services were derived (see Figure 5):  
• The customer process of patients evolves around the prevention and treatment of 
an illness. The sub-processes may differ in length and show that healthy persons 
can also be customers of pharma companies (‘prevent’).  
• The physician’s process focuses on patient treatment, i.e. providing advice and 
prescribing drugs. Included are knowledge management, i.e. systematic archiving 
of information from medical journals or newsletters, professional development, 
i.e. continuous medical education (CME) with online seminars etc. [4, 96], 
patient data management, i.e. the storage of patient data and their medical 
histories, and back-office, i.e. all administrative activities. 
• Hospital pharmacies have an emphasis on warehouse management. The 
pharmacy manager’s process starts with observing medical developments and 
searching information on sales figures, approval requirements and side effects of 
drugs. After checking inventory and comparing terms of delivery, the hospital 
pharmacist initiates a purchase order, the goods and the invoice are checked upon 
receipt, and the goods are assigned to the warehouse. 
• Compared to hospital pharmacies, ‘independent’ pharmacies are more sales- than 
logistics-driven. Dispensing drugs and advising customers is important here. 
Necessary support processes are prescription handling and ordering. 
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Figure 5: Customer Processes with Portal Services at Pharma Corp 
 
• The wholesaler’s process resembles the hospital’s customer process. Purchasing 
managers search for product information, new products on the market and data on 
drugs such as the size of shipping units, the number of tablets or capsules per 
pack. Terms such as payment and delivery dates are agreed with the pharma 
companies depending on local reference prices.7  
 
3.2.2 Portal Process Architecture 
In a second step Pharma Corp developed the process architecture and analyzed how the 
portal services were linked to the main CRM processes marketing, sales and service (see 
Figure 6). 
• Marketing mainly provides services for pre-transaction activities. Pharma Corp’s 
marketing is organized according to the therapeutic fields in which the company 
is active. Although a distinction is made between the customer segments 
                                                     
7 In Germany, for example, a directive on the price of medicines regulates the price range between pharma companies and 
wholesalers. Only discounts, terms of delivery and payment dates are freely negotiable.  
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‘hospitals’ and ‘physicians’ at the top level, all activities one level further down 
are directed at specific products. For a systematic evaluation of customer 
contacts, an active communication to customers, and personalized marketing 
campaigns, marketing defined all customer information to be collected by the 
sales force.  
• Sales is also organized according to hospitals and physicians, and product lines at 
the next level. To avoid that different sales reps visit the same customers, Pharma 
Corp has appointed key account managers who are not responsible for the 
success of an individual product but for success of certain customers. CRM 
supports them with information across product lines. 
• Call centers are a major element in Pharma Corp’s service area. A single 
telephone number (contact point) has been established for questions regarding 
products. Calls are automatically routed to the person or department concerned, 
depending on the call and the type of support required. CRM supports call center 
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Figure 6: Portal Process Architecture for Customer Segment ‘Patients’ 
 
The portal architecture in Figure 6 also includes the services of external providers. These 
electronic services offer specific highly standardized tasks which are charged on a time or 
usage basis. They enable a pharma company to focus on critical areas and have emerged 
for specific tasks in business processes, for horizontal tasks that may be applied in various 
business processes (content & transaction services), for the consolidation, the unique 
retrieval, and the automatic routing of information (integration services), as well as for 
network operation (IT operation services) [29, 34]. Figure 7 shows examples which were 
considered important for supporting the customer segments ‘patient’ and ‘physician’. 
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Business process services 
Online prescriptions,  
www.rxhub.net    ●    ●   
Appointment service 
www.healinx.com   ● ● ●     ● 
Immediate medical assistance 
www.getwellness.ch ● ● ● ● ●      
Online visit to the doctor’s  
www.healinx.com   ● ●    ●   
Professional training (x-rays) 
www.yxlon.com      ● ●    
Online hospital registration 
optimizer.sanalink.com    ●    ●  ● 
Continuous medical education 
www.medscape.com      ● ●    
Content & transaction services 
Health information 
www.pharmavista.net ●     ● ●    
Discussion forums 
www.getwellness.ch ● ● ● ● ● ● ●    
Patient dossier exchange 
optimizer.sanalink.com    ●  ●  ● ● ● 
Personal health data record 
www.webmd.com ●   ●       
Self-care tips  
www.webmd.com ● ●   ●      
Journal service  
www.medscape.com ●     ● ●    
Communities 
www.netdoktor.de ●   ●   ● ●   
Drug catalog and warnings 
www.drugstore.com    ●  ● ●  ● ● 
Drug check 
www.gesundheitscout24.de ●   ●  ●  ●   
Integration services 
Dictionaries of illnesses 
www.medterms.com ● ● ● ●  ● ● ●   
Dictionary of drugs 
www.medicineonline.com ● ● ● ●  ● ● ●   
Physician and therapist search 
www.ama-assn.org/aps  ●  ●    ●  ● 
Directories 
www.medizin.ch  ● ● ●  ●  ●  ● 
Figure 7: Electronic Services for Patient and Physician Portals 
 
These electronic services may also be pre-configured into a business collaboration 
infrastructure offered by a third party provider such as global healthcare exchange 
(GHX). At this moment, Pharma Corp is planning to integrate selected services 
bilaterally. The criteria which have been used were strategic relevance (task is not core to 
Pharma Corp’s business), cost (cost of service is below internal cost), and market power 
(established player in the market / standard solution).  
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3.2.3 System Architecture 
The system architecture implements the process architecture regarding (1) the 
applications which provide the functionality for the process portals and the CRM 
processes, regarding (2) the integration solution which provides semantic and syntactical 
compatibility for homogenized customer data, and regarding (3) the technical 
infrastructure for the secure technical connectivity. Since the infrastructure architecture 
uses standard Internet technology it is not elaborated here.  
As a global company with strong local country divisions Pharma Corp decided to develop 
a decentralized system architecture. To avoid incompatible customer data and the 
implementation of multiple different systems, corporate guidelines determine the each 
country’s configuration:  
• The application architecture which reflects the functional requirements in the 
processes marketing (analytical and mailing functionalities), sales (functionalities 
for planning and reporting of visits, expense, sample and congress management), 
and service (functionalities for call centers, e.g. automatic call recognition). The 
ERP application is used for product management, ordering, and sales; the CRM 
application for call center, sales force, and marketing purposes. 
• The customer information platform (CIP) is a key element of the integration 
architecture. CIP defines a customer data model and methods to integrate local 
and corporate customer data. Both CRM and ERP supply and use data from the 
CIP which consists of a data warehouse and master data management solution 
(MDM). The data warehouse integrates data from various heterogeneous systems 
and consolidates data for reporting purposes. MDM harmonizes the different field 
names and customer ID numbers into a corporate standard. 
• The choice of system vendors which was limited to SAP in the ERP area and 
Siebel or Update.com in the CRM area. While large countries use Siebel, smaller 
countries use Update’s Marketing Manager. Other CRM systems will be 
replaced. Standard configurations have also been developed for portals where a 
solution from BEA/ATG has been selected.  
 
Pharma Corp Customer





















































Legend: WHM: Warehouse Management, MES: Manufacturing Execution System, LIMS: Laboratory Information Management 
System, KAM: Key Account Management, TMS: Territory Management System, MIS: Management Information System, ERP: 
Enterprise Resource Planning, XML: Extended Markup Language  
Figure 8: System Architecture at Pharma Corp 
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4. Summary and Outlook 
Deregulation, cost pressures, and new Internet channels are forcing pharma companies to 
adopt customer-oriented strategies and to reflect the sustainability of their existing 
strategies. CRM systems and customer process portals are becoming strategic necessities 
that determine customer retention as well as the operational efficiency of sales and 
marketing processes. Pharma companies face transformations on three levels. The 
business architecture supports the positioning regarding the target customer segments and 
electronic intermediaries. The process architecture identifies customer processes for each 
segment and derives portal services which can also be sourced from external service 
providers. Finally, the system architecture reflects the organizational culture and enables 
interoperability across heterogeneous applications. Pharma Corp estimates that the CRM 
architecture leads to benefits in two areas.  
• CRM benefits. Since the implications of CRM on additional revenues are difficult 
to quantify, Pharma Corp focused on the efficiency of sales and marketing 
processes. For example, one branch office calculated an estimated increase in the 
sales force headcount from 530 to 940 until 2005 due to the amount of new 
products. CRM is expected to save approx. 190 of these additional sales reps 
since only A and B customers will be visited regularly in future, while C and D 
customers will be referred to the portals for product detailing. Besides manpower 
cost such as expenses, samples, advertising material and tied-up assets (e.g. 
laptops) are reduced. In another branch a more targeted communication with 
customers reduced the sales rep workload for a single product line by approx. 
25,000 visits (to physicians who never prescribe) per year (plus the associated 
costs for advertising material, samples and expenses). 
• Architecture benefits. Among the typical benefits of architectures are reduced 
redundancies which lead to reusable and interoperable solutions. For example, 
pre-configured portals for physicians can be implemented in multiple country 
organizations while development and maintenance skills are centralized in a 
dedicated organization unit, the portal factory. Pharma Corp has accelerated the 
portal development from previously 9-12 months to 2-3 months. Similar 
synergies are expected for the implementation of the CRM standard solutions 
Siebel and Update. Pharma Corp also expects that the architecture proves helpful 
in evaluating, positioning, and integrating new technologies (e.g. mobile 
technologies) at an early stage. 
 
From a research perspective the presented architecture framework is only a first step 
towards a systematic methodology for (re)engineering downstream relationships. This 
includes techniques for developing result documents at each level of the architecture. 
Further research is also necessary regarding the metrics for assessing the results of the 
transformation which link the architecture to the business goals such as customer 
orientation.  
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